M&A Analysis: July M&A Levels Reach Fever Pitch
Executive Summary
The summer season is proving to be a hot one for medtech M&A activity, with another busy month of deal-making in July. Twenty-five deals were announced and closed during the month, surpassing June's deal count and making it the month with the highest M&A activity to date.
You may also be interested in...
M&A Analysis: August Activity Cools As The Summer Closes
Medtech M&A activity slowed in the last month of summer with just 16 mergers and acquisitions recorded on the Medtech Insight M&A Deal Tracker. However, the month included one billion-dollar deal and several deals in the ophthalmological sector.
Invitae Scores M&A Double Whammy In Reproductive Health Dx
Genetic information specialist Invitae is spreading into the reproductive health market with the proposed acquisition of two genetic testing companies that are focused on this area. The addition of Good Start Genetics and Combinatrix will enable Invitae to gain a foothold in the lucrative perinatal. Prenatal and neonatal testing markets. These deals bring the total number of acquisitions made by Invitae to three this year so far.
Philips Persists With M&A Strategy; Snaps Up Ultrasound Dx Biz
Philips is strengthening its hand in cardiac ultrasound with the addition of German ultrasound firm TomTec Imaging Systems, its seventh acquisition of the year. Financial terms of the deal were not disclosed.